Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases
Bastian Dislich(University of Bern), Rupert Langer(Johannes Kepler University of Linz)
Cited by 21
Related Papers
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
|Cancer Cell|2023|246
Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
|Annals of Oncology|2009|241
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
|The Lancet Oncology|2017|223
<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal Cancer
|New England Journal of Medicine|2012|184